Premenstrual Syndrome. Premenstrual tension syndrome
Conditions
Interventions
Placebo
Intrvention group Zinc sulfate
Intervention 1: Intrvention group Zinc sulfate. Intervention 2: Control group Placebo.
Treatment - Drugs
Sponsors
Tarbiat Modares Univresity
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria were: being single, suffering from moderate to severe PMS based on PSST questionnaires, age between 20 and 35 year with regular and normal menstruation (menstrual cycle 22 to 35 days and duration of bleeding 3 to 7 days), Normal BMI (26-19) Exclusion criteria: cardiovascular, pulmonary, renal, diabetes, liver, gastrointestinal, gynecological, and thromboembolic diseases, including chronic migraines, mental illness, taking any medication, and being under severe stress such as death of loved ones etc in the past three months, smoking and alcohol consumption, and consuming too much or too little food based on the questionnaire 1
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of Premenstrual Syndrome. Timepoint: Before intervention, the first month, second month and third month after the intervention. Method of measurement: Psst Questionnaire.;Quality of life. Timepoint: Before intervention, the first month, second month and third month. Method of measurement: sf12 Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects, including gastrointestinal. Timepoint: After 3 month. Method of measurement: Questionnaire.;Tendency for future medication use. Timepoint: After 3 month. Method of measurement: Questionnaire.;Dysmenorrhea. Timepoint: After 3 month. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShiva Siahbazi
Tarbiat Modares University
Outcome results
None listed